产品名称 | NebuSelect™ Recombinant Mouse P-Selectin/CD62P, His-tag |
---|---|
目录号 | NBL-242133 |
别名 | P-Selectin/CD62P; FLJ45155; GMP140; GRMP; PADGEM; PSEL; P-Selectin; SELP; CD62P; CD62; LECAM3 |
外观 | see COA |
分子量 | Trp42-Ala709 |
CAS | N/A |
溶解度 | Water Soluble |
存储条件 | Short term 4℃; Long term -20℃. |
保存时间 | 2 years |
备注1 | Q01102 |
备注2 |
目录号 | 规格 | 价格 | 库存状态 | |
NBL-242133-100ug | 100ug | Inquire | Inquire | |
NBL-242133-1mg | 1mg | Inquire | Inquire | |
NBL-242133-Customized Size | N/A | Inquire | Inquire |
Product Name:
NebuSelect™ Recombinant Mouse P-Selectin/CD62P, His-tag
Catalog#:
NBL-242133
Description:
NebuSelect™ Recombinant Mouse P-Selectin/CD62P, His-tag(Cat#NBL-242133) is expressed in HEK293 with His tag at the C-Terminus.It contains Trp42-Ala709.
Species:
Mouse
Expression System:
HEK293
Molecular Weight:
The protein has a predicted MW of 81.1 kDa. Due to glycosylation, the protein migrates to 110-130 kDa based on Bis-Tris PAGE result.
Target Name:
P-Selectin/CD62P; FLJ45155; GMP140; GRMP; PADGEM; PSEL; P-Selectin; SELP; CD62P; CD62; LECAM3
Target Information:
P-selectin is critical in the progression of atherosclerosis as evidenced by knockout animal models where P-selectin knockout mice crossed with apoE deficient mice exhibit significantly reduced atherosclerosis and leukocyte recruitment in the plaque. A soluble form of P-selectin also exists, which may have pro-atherogenic and pro-thrombotic effects. Thus targeting of P-selectin remains a strong clinical candidate for developing novel therapeutic strategies in inflammatory diseases.
Amino Acid Sequence:
Trp42-Ala709
Purity:
>95%
Formulation:
see COA
Endotoxin:
<1EU/ug(LAL Method)
Storage:
4°C for short term.
-20°C for long term.
To get more information, please contact us freely.